Associate Dean, UCSF School of Medicine
Ken and Donna Derr -- Chevron Distinguished Professorship in Prostate Cancer, UCSF
Chair, Department of Urology, UCSF
Director, Strategic Planning and Clinical Services, UCSF Helen Diller Family Comprehensive Cancer Center
| CONTACT | |
|
(415) 353-7171 (appts) Box 1711, UCSF; San Francisco, CA 94143-1711 |
additional websites: |
| EDUCATION | |
|
University of California, Berkeley, BA, 1974, Zoology
|
|
| PROFESSIONAL EXPERIENCE | |
|
1984-1986 |
Fellow, Urology Service, Memorial Sloan-Kettering Cancer Center |
|
1985-1986 |
Clinical Fellow, American Cancer Society, Memorial Sloan-Kettering Cancer Center |
|
1986-1992 |
Assistant Professor in Residence, Dept. of Urology, University of California, S.F |
|
1992-1993 |
Associate Professor, Dept. of Urology, University of California, San Francisco |
|
1993-present |
Interim Chief of Urology, UCSF/Mt. Zion Medical Center |
|
1993-present |
Program Leader, Program in Urologic Oncology, UCSF Cancer Center |
|
1996-present |
Professor and Chair, Department of Urology, UCSF, San Francisco, CA |
|
2003-2007 |
Surgeon-in-Chief, UCSF Helen Diller Family Comprehensive Cancer Center |
|
2006-present |
Director of Clinical Services and Strategic Planning, UCSF Helen Diller Family Comprehensive Cancer Center |
|
2006-present |
Associate Dean, UCSF School of Medicine |
| HONORS & AWARDS | |
|
Procter & Gamble Resident Essay Contest-Third Prize, co-author, Western Section |
|
|
American Urological Association |
|
|
CIRCON/ACMI Essay Contest-Second Prize, co-author, Western Section |
|
|
American Urological Association |
|
|
Miley B. Wesson/Procter & Gamble Resident Essay Competition, |
|
|
Second Prize, co-author, Western Section, American Urological Association |
|
|
Joseph F. McCarthy/Circon ACMI, 1st Place Essay Contest, co-author, |
|
|
Western Section, American Urological Association |
|
|
1998 |
American Association of Genitourinary Surgeons |
|
2001 |
Ken and Donna Derr - Chevron Endowed Chair in Prostate Cancer |
|
2002 |
Clinical Society of the American Association of Genitourinary Surgeons |
|
2004 |
Ken and Donna Derr-ChevronTexaco Distinguished Professorship in Prostate Cancer |
|
2006-2008 |
President, American Board of Urology |
| SELECTED PUBLICATIONS | |
|
(selected from over 400) |
|
|
Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 15;112(12):2664-70, 2008. |
|
|
Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll PR, Kane CJ. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004. J Urol. 179(6):2131-5, 2008. |
|
|
Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR. Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database. Urol Oncol. 26(3):271-5, 2008. |
|
|
Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A. 17;105(24):8369-74, 2008. |
|
|
Cooperberg MR, Cowan J, Broering J, Carroll PR. High-risk prostate cancer in the United States, 1990-2007. World J Urol. 26(3):211-8, 2008. |
|
|
Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 113(1):78-83, 2008. |
|
|
Swanson MG, Keshari KR, Tabatabai ZL, Simko JP, Shinohara K, Carroll PR, Zektzer AS, Kurhanewicz J. Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. Magn Reson Med. 60(1):33-40, 2008. |
|
|
Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg L, Bailey DE Jr, Wallace ME, Kantoff PW, Carroll PR. Active surveillance for early-stage prostate cancer: review of the literature. Cancer 112(8);1650-9. Review. 2008. |
|
|
Frattaroli J, Weidner G, Knistrian AM, Kemp C, Daubenmier JJ, Marlin RO, Crutchfield L, Yglecias l, Carroll PR, Ornish D. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology. 72(6):1319-2,2008. |
|
|
Barocas DA, Cowan JE, Smith JA Jr, Carroll PR. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. J Urol.;180(4):1330-4; discussion 1334-5, 2008. |
|
|
Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, Magbanua MJ, Marlin R, Yglecias L, Carroll PR, Blackburn EH. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol.;9(11):1048-57, 2008. |
|
|
Hong YM, Hu JC, Paciorek AT, Knight SJ, Carroll PR. Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: Results from CaPSUREtrade mark. Urol Oncol. 2008. [Epub ahead of print]. |
|
|
White WM, Sadetsky N, Waters WB, Carroll PR, Litwin MS. Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database. J Urol;180(6):2409-13; discussion 2414, 2008. |
|
|
Wu AK, Cooperberg MR, Sadetsky N, Carroll PR. Health related quality of life in patients treated with multimodal therapy for prostate cancer. J Urol (6):2415-22; discussion 2422, 2008. |
|
|
Simone NL, Singh AK, Cowan JE, Soule BP, Carroll PR, Litwin MS. Pretreatment predictors of death from other causes in men with prostate cancer. J Urol 180(6):2447-51; discussion 2451-2, 2008. |
|
|
Isbarn H, Boccon-Gibod L, Carroll PR, Montorsi F, Schulman C, Smith MR, Sternberg CN, Studer UE. Androgen Deprivation Therapy for the Treatment of Prostate Cancer: Consider Both Benefits and Risks. Eur Urol. [Epub ahead of print]. |
|
|
Odisho AY, Fradet V, Cooperberg MR, Ahmad AE, Carroll PR. Geographic distribution of urologists throughout the United States using a county level approach. J Urol.181(2):760-5; discussion 765-6, 2008 |
|
|
Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR, Rubin MA, Scardino PT. Evaluating localized prostate cancer and identifying candidates for focal therapy. Urology;72(6 Suppl):S12-24, 2008. |
|
|
Zerbib M, Zelefsky MJ, Higano CS, Carroll PR. Conventional treatments of localized prostate cancer. Urology;72(6 Suppl):S25-35, 2008 |
|
|
Marberger M, Carroll PR, Zelefsky MJ, Coleman JA, Hricak H, Scardino PT, Abenhaim LL New treatments for localized prostate cancer. Urology;72(6 Suppl):S36-43, 2008. |
|
|
Breyer BN, Whitson JM, Carroll PR, Konety BR. Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer. Urol Oncol. 2009 Jan 24. [Epub ahead of print] |
|
|
Konety BR, Cooperberg MR, Carroll PR. Are age-based criteria the best way to determine eligibility for prostate cancer screening? Ann Intern Med. 3;150(3):220-1; author reply 221-2, 2009. |
|
|
Dall'era MA, Hosang N, Konety B, Cowan JE, Carroll PR. Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease. J Urol. 2009 Apr;181(4):1622-7; discussion 1627. Epub 2009 Feb 23. |
|
|
3/25/09 |
|
